Contact this trialFirst, we need to learn more about you.
SGLT2 Inhibitor
Canagliflozin for Diabetic Kidney Disease
Recruiting3 awardsPhase 4
Ann Arbor, Michigan
"This trial is looking at the effects of a drug called Canagliflozin on kidney function in people with Type 2 diabetes. They are looking for participants aged 18-80 who have
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.